These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10086586)

  • 21. Abciximab to prevent vessel closure after angioplasty.
    Med Lett Drugs Ther; 1995 Jun; 37(950):52-3. PubMed ID: 7760769
    [No Abstract]   [Full Text] [Related]  

  • 22. Administering abciximab. A new drug for preventing coronary restenosis.
    Strimike CL; Wojcik JM
    Nursing; 1997 Mar; 27(3):32aa-32dd, 32ff. PubMed ID: 9171622
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of abciximab during percutaneous coronary angioplasty reduces ischaemic events, but the cost is prohibitive.
    Mayosi BM; Latouf SE; Commerford PJ
    S Afr Med J; 1998 Feb; 88(2):130-1. PubMed ID: 9717492
    [No Abstract]   [Full Text] [Related]  

  • 24. Abciximab, a novel platelet-blocking drug: pharmacology and nursing implications.
    Mayer DM; Docktor WJ
    Crit Care Nurse; 1998 Apr; 18(2):29-37. PubMed ID: 9708118
    [No Abstract]   [Full Text] [Related]  

  • 25. Are tirofiban and abciximab identical in efficacy?
    Jafary FH
    Eur Heart J; 2006 Jan; 27(1):119-20; author reply 120. PubMed ID: 16278228
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of abciximab for aneurysm coiling.
    Kapur S; da Silva EJ
    Anaesthesia; 2006 Jul; 61(7):720-1. PubMed ID: 16792629
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of abciximab on the outcome of emergency coronary artery bypass grafting after failed percutaneous coronary intervention.
    Singh M; Nuttall GA; Ballman KV; Mullany CJ; Berger PB; Holmes DR; Bell MR
    Mayo Clin Proc; 2001 Aug; 76(8):784-8. PubMed ID: 11499816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abciximab in the treatment of ST-segment elevation myocardial infarction.
    Tan DS; Sim DK; Chan ES; Tan RS
    JAMA; 2005 Oct; 294(14):1760-1; author reply 1761. PubMed ID: 16219877
    [No Abstract]   [Full Text] [Related]  

  • 29. Bleeding risks and vascular complications following abciximab therapy for percutaneous coronary intervention: a new look at an old problem.
    Kereiakes DJ; Broderick TM; Abbottsmith C; Shimshak TM
    J Invasive Cardiol; 2000 Feb; 12(2):95-8. PubMed ID: 10731271
    [No Abstract]   [Full Text] [Related]  

  • 30. Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease.
    Faulds D; Sorkin EM
    Drugs; 1994 Oct; 48(4):583-98. PubMed ID: 7528131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic intravenous abciximab: a novel treatment for acute central retinal artery occlusion?
    Mendes JF; Amorim J; Calvão-Santos G
    Acta Ophthalmol; 2018 Feb; 96(1):e101-e102. PubMed ID: 28470954
    [No Abstract]   [Full Text] [Related]  

  • 32. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
    Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.
    Mehilli J; Kastrati A; Schulz S; Früngel S; Nekolla SG; Moshage W; Dotzer F; Huber K; Pache J; Dirschinger J; Seyfarth M; Martinoff S; Schwaiger M; Schömig A;
    Circulation; 2009 Apr; 119(14):1933-40. PubMed ID: 19332467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary stenting and use of abciximab.
    Alvarez JM
    Lancet; 1998 Oct; 352(9136):1311-2. PubMed ID: 9788484
    [No Abstract]   [Full Text] [Related]  

  • 35. Tensions remain over tPA for stroke.
    Mitka M
    JAMA; 2003 Mar; 289(11):1363-4. PubMed ID: 12636438
    [No Abstract]   [Full Text] [Related]  

  • 36. Readministration of abciximab in percutaneous coronary intervention.
    Fry ET
    J Invasive Cardiol; 1999 Apr; 11(4):251-8. PubMed ID: 10745525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single center experience with provisional abciximab therapy in complex lower limb interventions.
    Keo H; Diehm N; Baumgartner R; Husmann M; Baumgartner I
    Vasa; 2008 Aug; 37(3):257-64. PubMed ID: 18690593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial comment--Utility of abciximab during carotid stenting when distal protection is contraindicated.
    Levy EI; Hopkins LN
    Stroke; 2003 Nov; 34(11):2567. PubMed ID: 14576366
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gastrointestinal bleeding in a patient with acute myocardial infarction treated with primary coronary angioplasty and abciximab (ReoPro) administration].
    Gziut AI; Pastwa Ł; Słysz A
    Kardiol Pol; 2006 Mar; 64(3):334-6; discussion 337-8. PubMed ID: 16583343
    [No Abstract]   [Full Text] [Related]  

  • 40. IIb/IIIa platelet inhibitors in the management of coronary artery disease.
    Talley JD
    J Ark Med Soc; 1996 Oct; 93(5):237-9. PubMed ID: 8908943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.